Clinical Trial Update: Boceprevir Treatment in Liver Pre-transplant HCV Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating boceprevir for hepatitis C in liver transplant candidates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (Victrelis) (boceprevir)

Snippet

Sponsor: Hu Tsung-Hui | Conditions: Late Complication From Liver Transplant | Phase 3 | Status: UNKNOWN